medDARE, founded in 2020 and headquartered in Romania, is positioned at the intersection of AI, Health Care, and Medical Devices. As a trusted provider of data collection and annotation services, the company enhances healthcare AI algorithms and offers its own AI-powered innovations.
With ISO 9001 and 27001 certifications, medDARE ensures high-standard internal quality and data security processes. The company's services include access to over 3M+ secure, anonymized medical datasets from the US and EU, as well as data curation and anonymization performed by medical experts. Their comprehensive offerings also include AI-driven software development and quality assurance, providing robust support for both startups and Fortune 500 enterprises.
The company prides itself on transforming healthcare through technology, thus presenting a ripe opportunity for investors looking to partake in cutting-edge healthcare advancements. To date, medDARE remains open for investments as they continue to drive AI success and foster a healthier future.